Exploring the Latent Trait and the Measurement Properties of Korean World Health Organization Quality of Life-BREF Measure Applied to Cancer Survivors
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In general, measurement qualities of cross-culturally adapted quality of life (QOL) measures are altered in many aspects, although versions of them are well-validated measures. The latent trait and measurement qualities of the QOL measures for cancer-related samples should be considered when developing cross-culturally adapted measures. Objects: To investigate the latent trait of the translated into Korean World Health Organization Quality of Life-BREF (WHOQOL-BREF) administered to different cancer survivors who had palliative rehabilitation care service (PRCS). Methods: A cross-sectional study with 139 cancer survivors who had an experience of cancer survivorship with PRCS were conducted with a two-step analytic procedure including exploratory factor analysis (EFA) to confirm the latent trait and Rasch rating scale modeling to investigate the measurement qualities of the cross-culturally adapted WHOQOL-BREF measure. Results: While the original WHOQOL-BREF measure constitutes a 4-latent trait, the EFA reveals that 24 items constitute six substantial factors. The item loadings are predominantly spread over factors 1 through 4 in a mixed manner of the latent traits, while the loadings of ‘physical health’ and ‘environmental health’ latent traits show similarity to what the original measure intended to assess. The latent trait of the cross-culturally adapted WHOQOL-BREF measure administered to different cancer survivors is likely to reveal more dimensions than the original WHOQOL-BREF measure. Person reliability (i.e., analogous to Cronbach’s alpha) and separation are measured with 0.92 and 3.48, respectively. All items except the one item (medical treatment item) fit the Rasch rating model. Conclusion: Findings suggest that the latent trait and the measurement qualities of the cross-culturally adapted WHOQOL-BREF measure should be taken into consideration when applying versions of it to various populations.
Abstract
Background: In general, measurement qualities of cross-culturally adapted quality of life (QOL) measures are altered in many aspects, although versions of them are well-validated measures. The latent trait and measurement qualities of the QOL measures for cancer-related samples should be considered when developing cross-culturally adapted measures. Objects: To investigate the latent trait of the translated into Korean World Health Organization Quality of Life-BREF (WHOQOL-BREF) administered to different cancer survivors who had palliative rehabilitation care service (PRCS). Methods: A cross-sectional study with 139 cancer survivors who had an experience of cancer survivorship with PRCS were conducted with a two-step analytic procedure including exploratory factor analysis (EFA) to confirm the latent trait and Rasch rating scale modeling to investigate the measurement qualities of the cross-culturally adapted WHOQOL-BREF measure. Results: While the original WHOQOL-BREF measure constitutes a 4-latent trait, the EFA reveals that 24 items constitute six substantial factors. The item loadings are predominantly spread over factors 1 through 4 in a mixed manner of the latent traits, while the loadings of ‘physical health’ and ‘environmental health’ latent traits show similarity to what the original measure intended to assess. The latent trait of the cross-culturally adapted WHOQOL-BREF measure administered to different cancer survivors is likely to reveal more dimensions than the original WHOQOL-BREF measure. Person reliability (i.e., analogous to Cronbach’s alpha) and separation are measured with 0.92 and 3.48, respectively. All items except the one item (medical treatment item) fit the Rasch rating model. Conclusion: Findings suggest that the latent trait and the measurement qualities of the cross-culturally adapted WHOQOL-BREF measure should be taken into consideration when applying versions of it to various populations.
참고문헌 (28)
- WHO report on cancer:setting priorities, investing wisely and providing care for all, "World Health Organization", WHO, ~ (2020)
- 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
- "Palliative care" (2019)[URL]
- Dy SM, "Palliative care for cancer survivors", Med Clin North Am, 101(6), pp.1181~1196 (2017)
- Economou D, "Palliative care needs of cancer survivors", Semin Oncol Nurs, 30(4), pp.262~267 (2014)
- van Roij J, "Measuring health-related quality of life in patients with advanced cancer : a systematic review of self-administered measurement instruments", Qual Life Res, 27(8), pp.1937~1955 (2018)
- Cieza A, "Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF)", Qual Life Res, 14(5), pp.1225~1237 (2005)
- Efthymiadou O, "Health related quality of life aspects not captured by EQ-5D-5L : results from an international survey of patients", Health Policy, 123(2), pp.159~165 (2019)
- "Development of the World Health Organization WHOQOLBREF quality of life assessment", Psychol Med, 28(3), pp.551~558 (1998), The WHOQOL Group
- choi bongsam, "Construct Validity of a Korean Version of the WHOQOL-BREF and EQ-5D Questionnaire Applied on Various Cancer Survivors Undergoing Palliative Rehabilitation Programs", 한국전문물리치료학회지, 27(3), pp.212~219 (2020), 한국전문물리치료학회[DOI]
- Leary MR, "Handbook of individual differences in social behavior", pp.318~329 (2009), Guilford Press
- Cacioppo JT, "The need for cognition", J Pers Soc Psychol, 42(1), pp.116~131 (1982)
- McHorney CA, "Generic health measurement : past accomplishments and a measurement paradigm for the 21st century", Ann Intern Med, 127(8 Pt 2), pp.743~750 (1997)
- Ashley L, "Traditional and Rasch psychometric analyses of the Quality of Life in Adult Cancer Survivors(QLACS)questionnaire in shorter-term cancer survivors 15 months post-diagnosis", J Psychosom Res, 77(4), pp.322~329 (2014)
- Efthymiadou O, "Differentiation of health-related quality of life outcomes between five disease areas : results from an international survey of patients", Int J Technol Assess Health Care, 34(5), pp.498~506 (2018)
- Yang Y, "An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment", Qual Life Res, 22(10), pp.2813~2828 (2013)
- Min SK, "Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF", Qual Life Res, 11(6), pp.593~600 (2002)
- Cattell RB, "The scree test for the number of factors", Multivariate Behav Res, 1(2), pp.245~276 (1966)
- Tavakol M, "Factor analysis : a means for theory and instrument development in support of construct validity", Int J Med Educ, 11, pp.245~247 (2020)
- Bond TG, "Applying the Rasch model: fundamental measurement in the human sciences" (2007), Lawrence Erlbaum Associates Publishers
- Smith AB, "A Rasch and factor analysis of the functional assessment of cancer therapygeneral(FACT-G)", Health Qual Life Outcomes, 5, pp.19~ (2007)
- Embretson SE, "Item response theory for psychologists" (2000), Lawrence Erlbaum Associates Publishers
- Titlestad KB, "Translation, cross-cultural adaption and measurement properties of the evidence-based practice profile", BMC Res Notes, 10(1), pp.44~ (2017)
- Beaton DE, "Guidelines for the process of cross-cultural adaptation of self-report measures", Spine(Phila Pa 1976), 25(24), pp.3186~3191 (2000)
- Ferraz MB, "Cross cultural adaptation of questionnaires : what is it and when should it be performed?", J Rheumatol, 24(11), pp.2066~2068 (1997)
- Guyatt GH, "The philosophy of health-related quality of life translation", Qual Life Res, 2(6), pp.461~465 (1993)
- Streiner DL, "Starting at the beginning : an introduction to coefficient alpha and internal consistency", J Pers Assess, 80(1), pp.99~103 (2003)
- Lin CY, "Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis", J Formos Med Assoc, 118(1 Pt 2), pp.215~222 (2019)